InsidersTradesSigma
Discover the full record of transactions filed by F2 Vision SCS. Director active across 1 companies, notably Cullinan Oncology, Inc.. In total, 3 filings have been logged. Total volume traded: €2.4m. The latest transaction was disclosed on 12 May 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations